Drug Type Monoclonal antibody |
Synonyms RTX 002, RTX-002 |
Target |
Mechanism PD-1 agonists(Programmed cell death protein 1 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization RubrYc Therapeutics, Inc.Startup |
Active Organization RubrYc Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | US | RubrYc Therapeutics, Inc.Startup | - |